RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2005;98:421-422
doi:10.1258/jrsm.98.9.421
© 2005 Royal Society of Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernando, A. I
Right arrow Articles by Pandit, J. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Intravitreal triamcinolone acetonide for refractory diabetic macular oedema

Arosha I Fernando BSc MRCOphth     Jyotin C Pandit MSc FRCSEd  

Western Eye Hospital, 171 Marylebone Road, London NW1, UK



View larger version (125K):

[in a new window]
  		Figure 1. Fluorescein angiogram showing increased size and irregularity (arrows) of the foveal avascular zone

 


View larger version (63K):

[in a new window]
  		Figure 2. Ocular coherence tomogram showing (a) diabetic macular oedema with cystoid space formation. (b) Reduction in macular thickness 1 month after intravitreal triamcinolone injection (in colour online)

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Get Ahead Surgery 100 EMQs for Finals

 Anatomy Flash Cards Exam Doctor - The interactive revision site for trainee doctors